Protocol to Obtain Blood Samples for Leukemia Research
The blood sample will be used in the laboratory to perform studies focusing on Chronic
Lymphocytic Leukemia (CLL).
- Patients undergoing routine blood draws as part of their ongoing follow-up for
Chronic Lymphocytic Leukemia (CLL) at the Norris Cotton Cancer Center of DHMC.
- Patients who have received cytotoxic drug, oral or intravenous steroid or targeted
antibody therapy for CLL or other disease process within the past 6 months are
excluded. Use of intravenous immunoglobulin (IVIg) is not a reason for exclusion.
Type of Study:
Observational Model: Cohort, Time Perspective: Prospective
To determine the frequency with which CLL cells incubated ex vivo with vincristine undergo rapid interphase apoptosis.
Outcome Time Frame:
Christopher H Lowrey, MD
Dartmouth-Hitchcock Medical Center
United States: Institutional Review Board
- Chronic Lymphocytic Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
|Dartmouth-Hitchcock Medical Center
||Lebanon, New Hampshire 03756